第四範式(06682.HK)與臨港集團簽訂合作協議
據內媒報道,第四範式(06682.HK)將於臨港集團相關的園區合作建立「三中心一平台」,當中包括人工智能產業賦能中心、人工智能創新研發中心、人工智能創投孵化中心、國際數據及算力綜合服務平台。雙方於近日舉行戰略合作簽約儀式,當中第四範式華東區域總部,擬日後將落戶臨港集團下屬的漕河涇開發區。
第四範式董事會主席、執行董事兼首席執行官戴文淵表示,公司與臨港集團將以戰略協議簽約為契機,在徐匯區、上海交通大學等政府和高校的支持下,圍繞人工智能前沿技術、產業生態和人才培養等方面共同開展深度合作,為發展新質生產力貢獻力量,助上海打造更具競爭力的世界級人工智能產業集群。(js/u)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.